Advertisement

Topics

AtheroGenics Incorporated Company Profile

14:12 EST 17th November 2017 | BioPortfolio

AtheroGenics is an emerging pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, rheumatoid arthritis and asthma.

AtheroGenics has cultivated a drug discovery and development capability directed toward rapidly creating and transporting small molecule therapeutics into the clinical testing arena to ultimately establish the safety and efficacy of novel compounds that address serious unmet medical needs

Location

8995 Westside Parkway
Alpharetta
30004
United States of America

Contact

Phone: 678 336 2500
Fax: 770 447 1886
Email: investor@atherogenics.com.


News Articles [1 Associated News Articles listed on BioPortfolio]

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [37 Associated Companies listed on BioPortfolio]

AtheroGenics Incorporated

AtheroGenics is an emerging pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosi...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

COOK BIOTECH INCORPORATED

COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...

LCG Systems

Founded by Conrad Kenley in 1990, LCG, Inc. is a leader in providing grants management solutions to health and social services agencies. LCG Systems (a subsidiary of LCG, Inc.) ...

More Information about "AtheroGenics Incorporated" on BioPortfolio

We have published hundreds of AtheroGenics Incorporated news stories on BioPortfolio along with dozens of AtheroGenics Incorporated Clinical Trials and PubMed Articles about AtheroGenics Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AtheroGenics Incorporated Companies in our database. You can also find out about relevant AtheroGenics Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record